NEW YORK (GenomeWeb News) – Nanosphere said Friday that it will offer 15 million shares of its common stock in a public offering priced at $1.75 per share.

The Northbrook, Ill.-based molecular diagnostics company said that it expects to bring in net proceeds of around $24.1 million, or $27.7 million if the underwriters exercise their overallotment option of 2,250,000 shares in full. Funds from the offering will be used for general corporate purposes and working capital, Nanosphere said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.